A New Cancer Rehabilitation Process for Chemotherapy-Induced Foot Neuropathy Using Orthopedic Devices

Recruiting now · Not applicable

Conditions studied: Polyneuropathy, Breast Cancer

In brief

The goal of this clinical study is to evaluate a new process for assessing and alleviating chemotherapy-induced peripheral neuropathy in the feet in patients treated with chemotherapy for early stage breast cancer. It will also compare two orthopedic interventions for symptom relief. The main questions it aims to answer are: Can an orthopedic silicone orthosis reduce chemotherapy-induced peripheral neuropathy symptoms in the feet? How does the effectiveness of the silicone orthosis compare to standard orthopedic treatment with insoles and shoes? Participants will: Use either a silicone orthosis or standard orthopedic treatment Have contact with the clinic for assessments and follow-ups Report their symptoms and functional improvements over time

Key facts

Study ID

NCT06904989

Run by

Vastra Gotaland Region

People needed

40

Starts

2024-12-01

Expected to finish

2025-10-01

Last updated by the study team

2025-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with breast cancer receiving treatment at the Oncology Department, Sahlgrenska University Hospital (SU).
• Have undergone treatment with taxanes.
• Aged 18 years or older.
• Able to understand spoken and written Swedish.
• Patients who can ambulate with or without assistive walking devices.
• CTCAE grading above 2 at a medical visit after completing treatment.

You may not qualify if…

• Bilateral amputation at the thigh level.
• Previously diagnosed neurological disease or neurological impairment affecting the feet.

Where it is running

• Sahlgrenska University Hospital — Gothenburg, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.